Lithotripsy

SKIA Develops SKIA_Breast, AR Navigation on Patient Body for Doctors

Retrieved on: 
Monday, May 9, 2022
Medical Devices, Health, Technology, Hospitals, Surgery, Software, Vibration, MRI, Lithotripsy, Shock, Johnson & Johnson, Patient, Clinical trial, CT, Radiation exposure, Patent, Hospital, Skin, Tissue, Spine, Mark (given name), Education, Liver, CEO, SKIA, Skull, AR, 3D, Augmented reality, Multimedia, Medical imaging

Without having to visualize a two-dimensional image on the monitor as three-dimensional, the surgeon can concentrate more on the operation.

Key Points: 
  • Without having to visualize a two-dimensional image on the monitor as three-dimensional, the surgeon can concentrate more on the operation.
  • SKIA_Breast can see through the human body, so it helps to reduce any deviation of skill level according to surgical experience.
  • SKIA Co., Ltd. is a medical extended reality software development startup which was established on September 1, 2018.
  • In the future, we will develop a solution that can be applied to other organs such as liver and pancreas.

Conavi Medical’s Novasight Hybrid System Now In Use at Sunnybrook Health Sciences Centre

Retrieved on: 
Thursday, April 28, 2022
General Health, Medical Devices, Health, Clinical Trials, Cardiology, Veteran, Volunteering, CEO, Artery, OCT, Patient, Blood, Education, Sunnybrook Health Sciences Centre, Lithotripsy, Canton, Cardiovascular disease, Health Canada, University, Food, Cancer, Ministry, Rehabilitation, Adoption, Heart, MHLW, Physician, Sunnybrook, Research, Program, Sunnybrook Research Institute, IVUS, SRI, Injury, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Medical imaging, Health

Conavi Medical Inc. ( www.conavi.com ), a leader of hybrid imaging guidance for common minimally invasive heart procedures, and Sunnybrook Health Sciences Centre, today announced that the Novasight Hybrid System is now being used for clinical procedures by interventional cardiologists as part of the Schulich Heart Program.

Key Points: 
  • Conavi Medical Inc. ( www.conavi.com ), a leader of hybrid imaging guidance for common minimally invasive heart procedures, and Sunnybrook Health Sciences Centre, today announced that the Novasight Hybrid System is now being used for clinical procedures by interventional cardiologists as part of the Schulich Heart Program.
  • The hybrid intravascular ultrasound (IVUS) and optical coherence tomography (OCT) imaging platform, now called Novasight Hybrid System, was initially invented at Sunnybrook Research Institute (SRI) by Dr. Brian Courtney, a scientist and interventional cardiologist.
  • In fact, its a key part of our strategic plan, said Andy Smith, President and CEO of Sunnybrook Health Sciences Centre.
  • Novasight Hybrid System has 510(k) clearance from the U.S. Food and Drug Administration, and regulatory approval for clinical use from Health Canada, and the Ministry of Health, Labor and Welfare (MHLW) in Japan.

Ra Medical Systems Reports 2021 Fourth Quarter and Full Year Financial Results

Retrieved on: 
Wednesday, March 23, 2022
Diabetes, Health, Cardiology, Medical Devices, EBITDA, Private Securities Litigation Reform Act, Regulation, Lithotripsy, Lipid, Vascular disease, Sale, Marketing, Trial of the century, Forward-looking statement, Paycheck Protection Program, Growth, NYSE, GAAP, Patient, Laser, SEC, Investor relations, Research, Degenerative disease, Lists of disasters, Dermatology, PPP, U.S. Securities and Exchange Commission, Catheter, Industry, Technology, Review, Depreciation, COVID-19, Disclosure, Time, CA, Physician, Fracture, Income, Adjustment, Regulation Fair Disclosure, News, FDA, Atherectomy, Engineering, Protein, Annual report, Table, Security (finance), Medical device, Pharmaceutical industry, Video game, Lithium, Bookkeeping, Fossil fuel, Animal, Ridesharing company

Net revenue for the fourth quarter of 2021 consisted of product sales of $5,000, compared with no net revenue for the fourth quarter of 2020.

Key Points: 
  • Net revenue for the fourth quarter of 2021 consisted of product sales of $5,000, compared with no net revenue for the fourth quarter of 2020.
  • Total cost of revenue for the fourth quarter of 2021 was $0.3 million, compared with $0.4 million for the fourth quarter of 2020.
  • Research and development expenses for the fourth quarter of 2021 were $3.7 million, which included $0.1 million in stock-based compensation, compared with $3.4 million for the fourth quarter of 2020, which included $0.1 million in stock-based compensation.
  • Adjusted EBITDA for the fourth quarter of 2021 was negative $7.8 million, compared with negative $8.8 million for the fourth quarter of 2020.

Global Lithotripsy Devices Industry Worth $1.78B by 2026 - Discover the Leading Products, Services, Developments, and Competitors - ResearchAndMarkets.com

Retrieved on: 
Wednesday, February 23, 2022
Surgery, Health, Medical Devices, Risk, Urology, Government, Awareness, Ureter, COVID-19, Dornier, ESWL, Competitive landscape, US, Woman, Olympus Corporation, Chronic kidney disease, National Kidney Foundation, TMS, Incidence, Lithotripsy, Anesthesia, European Association of Urology, Growth, Man, MDR, IVL, Adoption, Person, Boston Scientific, CAGR, CT, Kidney, Human services, Population, Efficiency, EMS, Prevalence, EDAP, USD, Patient, Fluoroscopy, Physician, Percussion section, Bleeding, ESRD, Coronary artery disease, Ageing, Acquisition, Medical device regulation, FDA, Public employment services in the European Union, Plaque, Technology, Rock, Shock, Certification, Medical imaging, Pharmaceutical industry, Agriculture, Medical device

Owing to the occurrence of stones in various parts of the body, the Lithotripsy Devices market will rise significantly.

Key Points: 
  • Owing to the occurrence of stones in various parts of the body, the Lithotripsy Devices market will rise significantly.
  • Thus, the burgeoning cases of urolithiasis will contribute to the Global Lithotripsy Devices Market growth.
  • Such technological advancement in the field of Lithotripsy Devices is likely to boost the Global Lithotripsy Devices Market during the forecast period.
  • In the by-type segment of the Lithotripsy Devices market, the Extracorporeal Shock Wave Lithotripsy Devices (ESWL) market segment will hold a significant share in the Global Lithotripsy Devices market.

Cardiovascular Systems, Inc. Announces Development of Intravascular Lithotripsy Technology for the Treatment of Coronary and Peripheral Artery Diseases

Retrieved on: 
Thursday, January 13, 2022
Health, Medical Devices, Cardiology, Calendar, CSI, Fracture, Patient, Technology, PCI, News, Moyamoya disease, Annual report, Man, Lithotripsy, Korea Disease Control and Prevention Agency, Kidney, Center, Clinical trial, Private Securities Litigation Reform Act, CAD, SEC, Form 10-K, Plaque, Organization, Degenerative disease, Population, Knee, NASDAQ, Coronary artery disease, Death, CEO, IVL, Leg, Atherosclerosis, Obesity, Artery, View, Form 10-Q, Pain, Program, Heart, Diabetes, PAD, MACE, Testosterone and the cardiovascular system, Risk, Calcium, Walking, Amputation, Twitter, FDA, Cardiovascular disease, Prevalence, Hospital, Physician, Woman, Pharmaceutical industry, Medical imaging, Cardiovascular Systems, Inc., Coronary Artery Disease (CAD), Peripheral Artery Disease (PAD), CARDIOVASCULAR SYSTEMS, INC., CORONARY ARTERY DISEASE (CAD), PERIPHERAL ARTERY DISEASE (PAD)

Lithotripsy has been used successfully for many years in the treatment of kidney and gall stones, and more recently has found application in treatment of calcified coronary and peripheral arteries.

Key Points: 
  • Lithotripsy has been used successfully for many years in the treatment of kidney and gall stones, and more recently has found application in treatment of calcified coronary and peripheral arteries.
  • The CSI IVL systems are designed to improve upon the limitations of incumbent technology, allowing physicians to cross and treat more challenging atherosclerotic lesions.
  • In coronary, CSIs current product offering, which is focused on the treatment of severely calcified coronary arteries using orbital atherectomy, targets 12% of percutaneous coronary interventions (PCI).
  • CSI is a registered trademark of Cardiovascular Systems, Inc. All other trademarks cited herein are owned by their respective owners.

Global Next-Generation Ultrasound System Market Forecast 2021-2026 | Includes Profiles of BK Medical, Butterfly Network, Canon, Clarius Mobile Health, Esaote, and More - ResearchAndMarkets.com

Retrieved on: 
Friday, October 15, 2021
Medical Devices, Health, Prevalence, Government, Hospital, Device file, Industry, Adoption, 3D, CAGR, Lithotripsy, Growth, Benchmarking, Laboratory, PlayStation Portable system software, Product type, Doppler ultrasonography, Global, Investment, Conditional sentence, High-intensity focused ultrasound, Wearable, COVID-19, R, Medical device, Medical imaging, Mobile phone

The need for more precise and accurate imaging requires a high-end ultrasound machine, thereby fueling the demand for the next-generation ultrasound system.

Key Points: 
  • The need for more precise and accurate imaging requires a high-end ultrasound machine, thereby fueling the demand for the next-generation ultrasound system.
  • What are the overall market statistics or estimates (Market Overview, Market Size - by Value, Forecast Numbers, Market Segmentation, and Market Shares) of the Global Next-Generation Ultrasound System Market?
  • What are the key innovations, opportunities, current & future trends, and regulations in the Global Next-Generation Ultrasound System Market?
  • What are the key results derived from the market surveys conducted during the Global Next-Generation Ultrasound System Market study?

Copper Ridge Surgery Center Becomes First ASC in Region to Introduce MOSES Laser

Retrieved on: 
Tuesday, September 28, 2021
Medical Devices, Health, Technology, Hospitals, Surgery, Hardware, Adoption, Gynaecology, ASC, Hand, Elective surgery, Veni, vidi, vici, Observation, Nose, Efficiency, Ear, BPH, DO, Surgeon, Patient, Wrist, Ambulatory Surgery Center Association, Copper Ridge Dolomite, Urology, Physician, Accreditation, MD, Â, Ankle, Gastroenterology, Munson Medical Center, Pulse, Joint, General surgery, Traverse, Ophthalmology, Prostate, Kidney, Technology, Learning, Foot, Lithotripsy, AAAHC, Hospital, Silviculture

Copper Ridge Surgery Center , Michigans state-of-the-art freestanding ambulatory surgery center (ASC), has become the first ASC facility in the northern part of the state to offer same-day treatment of kidney stones and benign enlarged prostate using the MOSES Pulse 120H by Lumenis , an advancement in minimally invasive laser technology.

Key Points: 
  • Copper Ridge Surgery Center , Michigans state-of-the-art freestanding ambulatory surgery center (ASC), has become the first ASC facility in the northern part of the state to offer same-day treatment of kidney stones and benign enlarged prostate using the MOSES Pulse 120H by Lumenis , an advancement in minimally invasive laser technology.
  • Copper Ridge urologist Andrew Luea, DO, said that the MOSES laser technology offers notable advantages to those undergoing lithotripsy, as well.
  • About Copper Ridge: Copper Ridge Surgery Center, Michigans premier freestanding ambulatory surgery center, is a multi-specialty outpatient facility that performs more than 22,000 surgical cases a year.
  • Copper Ridge Surgery Center has achieved AAAHC accreditation continuously since it opened in 2004.

New Kidney Stone Program at AHN's Allegheny Valley Hospital Provides Advanced Care 24/7 for Painful Condition

Retrieved on: 
Wednesday, September 15, 2021
Allegheny Health Network, Snack, Program, Water, CT, Obstetrics, AVH, Lisa Jackson Pulver, Red meat, Urology, Urethra, Patient, Lithotripsy, Blood, Risk, Salt, Kidney, Grain, Physician, Sodium, Diet, Hospital, AHN, Time-invariant system, Sand, Coffee, Medical imaging

NATRONA HEIGHTS, Pa., Sept. 15, 2021 /PRNewswire-PRWeb/ --Under the direction of Triangle Urology's Herman Bagga, MD, Allegheny Health Network's Allegheny Valley Hospital has established a new program that offers advanced care around the clock for patients who suffer from painful kidney stones.

Key Points: 
  • NATRONA HEIGHTS, Pa., Sept. 15, 2021 /PRNewswire-PRWeb/ --Under the direction of Triangle Urology's Herman Bagga, MD, Allegheny Health Network's Allegheny Valley Hospital has established a new program that offers advanced care around the clock for patients who suffer from painful kidney stones.
  • Kidney stones occur primarily in individuals who consume a diet high in sodium and animal protein, and low in hydration.
  • "They can be as small as a grain of sand or as large as a pearl," said Dr. Bagga.
  • "The biggest risk factor for future stone formation is having a prior stone," said Dr. Bagga.

PIH Health Good Samaritan Hospital Offers First-of-Its-Kind Treatment for Heart Disease

Retrieved on: 
Thursday, August 19, 2021
Coronary artery disease, Cardiovascular disease, College, IBM Watson Health, Degenerative disease, Atherectomy, Twitter, Calcium, Instagram, Cancer, Stent, Fracture, Physician, Round Top hospitals, View, Hospice, Cardiology, Man, Health, Death, Heart, CHIME, Plaque, Multimedia, Elective surgery, PIH, College of Healthcare Information Management Executives, Hospital, Lithotripsy, Safety, Risk, Patient, IVL, PIH Health, Technology, Pharmaceutical industry, Medical imaging

Heart disease is the leading cause of death for both men and women.iEach year, more than 600,000 people in the United States die of heart disease.

Key Points: 
  • Heart disease is the leading cause of death for both men and women.iEach year, more than 600,000 people in the United States die of heart disease.
  • As people with heart disease, specifically coronary artery disease, grow older and their disease progresses, plaque in the arteries evolves into calcium deposits, which harden the narrowing in the artery.
  • Physicians often use stents to open an artery, and of the approximately one million patients that undergo a stent procedure each year, 30 percent have problematic calcium that increases their risk for adverse events by preventing the stent from expanding.ii
    "Cardiologists at PIH Health Good Samaritan Hospital are committed to providing patients with access to many of the latest cardiovascular innovations to treat heart disease," said Guy Mayeda MD, interventional cardiologist at PIH Health Good Samaritan Hospital.
  • The fully integrated network is comprised of PIH Health Downey Hospital, PIH Health Good Samaritan Hospital, PIH Health Whittier Hospital, 35 outpatient medical office buildings, a multispecialty medical (physician) group, home healthcare services and hospice care, as well as heart, cancer, digestive health, orthopedics, women's health, urgent care and emergency services.

Results from 16 Significant Vascular Interventional Clinical Trials to Be Presented for the First Time at VIVA21

Retrieved on: 
Tuesday, August 10, 2021
NCDR, Disrupt, Observational study, Education, Lithotripsy, Calcification, VIVA, Physician, Trial of the century, Wynn Las Vegas, Signs and symptoms, Blood vessel, Patient, Virtual, Vascular disease, Peripheral vascular examination, Research, Registry, Awareness, Multimedia, SAN, Treatment, Medical imaging, Pharmaceutical industry

VIVA (Vascular InterVentional Advances) is an annual vascular education symposium that brings together a global, multispecialty faculty to present a variety of talks and live case presentations from clinical centers around the world.

Key Points: 
  • VIVA (Vascular InterVentional Advances) is an annual vascular education symposium that brings together a global, multispecialty faculty to present a variety of talks and live case presentations from clinical centers around the world.
  • Attendees include an audience of interventional cardiologists, interventional radiologists, vascular surgeons, and endovascular medicine specialists.
  • Any members of the press planning to attend or press who would like access the sessions virtually should contact [email protected] .
  • Our team of specialists in vascular medicine, interventional cardiology, interventional radiology, and vascular surgery is driven by the passion to advance the field and improve patient outcomes.